CL vs FOLD · P/E 34, rev $20.38B vs rev $528.3M
Colgate-Palmolive Company (CL) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
CL currently screens at market cap $70.88B and trailing P/E 34.3. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the CL and FOLD stock pages for the full models.
Not investment advice.